Results 201 to 210 of about 317,186 (262)

Impact of extended insurance coverage on survival outcomes among patients with metastatic colorectal cancer in Taiwan

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Predetermined treatment duration limits (PTDLs) are often used by Taiwan's National Health Insurance Administration to contain healthcare costs, but they may compromise patient outcomes. Therefore, we studied Taiwan's 2017 extension of the bevacizumab PTDL from 24 to 36 weeks in metastatic colorectal cancer (mCRC) to evaluate whether prolonged ...
Wei‐Ming Huang   +6 more
wiley   +1 more source

Cardiac implantable electronic devices in heart failure: needs, challenges, and real-world implementation. [PDF]

open access: yesHeart Fail Rev
Žižek D   +9 more
europepmc   +1 more source

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić   +7 more
wiley   +1 more source

Delivery mode and maternal health conditions before and after childbirth: A population-based cohort study from Estonia. [PDF]

open access: yesActa Obstet Gynecol Scand
Täär K   +7 more
europepmc   +1 more source

Immunogenic Cell Death Induced by EEO in Breast Cancer Cells Promotes Dendritic Cell Activation in a CRT-Dependent Manner. [PDF]

open access: yesLife (Basel)
Shin SA   +10 more
europepmc   +1 more source

Sudden cardiac death in younger adults: a comparative analysis of coronary and non-coronary causes. [PDF]

open access: yesInt J Cardiol Heart Vasc
Thiesing P   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy